0 Комментарии
0 Поделились
261 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Neuroblastoma Cancer Market: How Is Anti-GD2 Immunotherapy Becoming the Fastest-Growing Frontline Treatment Paradigm?Anti-GD2 monoclonal antibody therapy for high-risk neuroblastoma — the dinutuximab, naxitamab, and emerging humanized anti-GD2 agents targeting the disialoganglioside antigen densely expressed on neuroblastoma cells, representing the fastest-evolving treatment modality in the global pediatric oncology landscape — creates the most clinically transformative market segment, with the...0 Комментарии 0 Поделились 18 Просмотры 0 предпросмотр
-
Personalized Cancer Vaccines Market Revolutionizes Oncology Through Precision ImmunotherapyAccording to the latest report published by Data Bridge Market Research, the Personalized Cancer Vaccines Market CAGR Value This Personalized Cancer Vaccines Market research report is a comprehensive synopsis on the study of Personalized Cancer Vaccines Market industry and its influence on the market environment. Some of the competitor strategies can be mentioned here...0 Комментарии 0 Поделились 7 Просмотры 0 предпросмотр
-
Self-Amplifying RNA Cancer Immunotherapy Platforms Market Growth, Global Outlook, Analysis, Trends and Forecast Analysis By FMINEWARK, DE | The Self-Amplifying RNA Cancer Immunotherapy Platforms Market was valued at USD 94.0 million in 2025 and is expected to reach USD 112.0 million in 2026. Expanding at a CAGR of 19.10%, the market is projected to achieve USD 643.2 million by 2036. This growth reflects a critical shift in oncology toward dose-sparing RNA technologies that address systemic toxicity...0 Комментарии 0 Поделились 909 Просмотры 0 предпросмотр
-
Self-Amplifying RNA Cancer Immunotherapy Platforms Market Growth, Global Outlook, Analysis, Trends and Forecast Analysis By FMINEWARK, DE | The Self-Amplifying RNA Cancer Immunotherapy Platforms Market was valued at USD 94.0 million in 2025 and is expected to reach USD 112.0 million in 2026. Expanding at a CAGR of 19.10%, the market is projected to achieve USD 643.2 million by 2036. This growth reflects a critical shift in oncology toward dose-sparing RNA technologies that address systemic toxicity...0 Комментарии 0 Поделились 938 Просмотры 0 предпросмотр
-
Skin Cancer Therapeutics Market: How Is Merkel Cell Carcinoma Immunotherapy Transforming a Rare Aggressive Cancer?Merkel cell carcinoma (MCC) immunotherapy — the anti-PD-L1 avelumab and anti-PD-1 pembrolizumab approvals for advanced MCC representing the dramatic efficacy in a rare, aggressive neuroendocrine skin cancer in the global skin cancer therapeutics market — creates the highest unmet need transformation segment, with the Skin Cancer Therapeutics Market reflecting MCC immunotherapy as...0 Комментарии 0 Поделились 283 Просмотры 0 предпросмотр
-
The 2026 Lung Cancer Therapeutics Market: Navigating the Era of Molecular Precision and Immunotherapy IntegrationThe oncology sector is witnessing a historic pivot in how pulmonary malignancies are addressed. In 2026, the Lung Cancer Therapeutics Market has moved definitively away from non-specific treatments toward a framework of molecular targeting and immune-system recalibration. This shift is driven by a deeper understanding of genetic drivers and the integration of high-velocity data into...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Tumor Infiltrating Lymphocytes Market Size, Cancer Immunotherapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Tumor Infiltrating Lymphocytes Market Data Bridge Market Research analyses that the tumor infiltrating lymphocytes market which was USD 9.17 billion in 2022, is expected to reach USD 25.5 billion by 2030, at a CAGR of 12.00% during the forecast period 2023 to 2030.This Tumor Infiltrating Lymphocytes...0 Комментарии 0 Поделились 43 Просмотры 0 предпросмотр
-
CAR T-Cell Therapy & Immune Checkpoint InhibitorsTwo of the most transformative advances in modern oncology are CAR T-Cell Therapy and Immune Checkpoint Inhibitors. Both harness the immune system to fight cancer, but they do so through fundamentally different mechanisms. Checkpoint inhibitors are off-the-shelf antibodies that release the brakes on the immune system, enabling pre-existing T cells to attack tumors. CAR T-cell...0 Комментарии 0 Поделились 48 Просмотры 0 предпросмотр
-
Precision Oncology Advances Accelerate the Personalized Cancer Vaccines MarketLatest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value The market insights gained through this keyword market research analysis report facilitate a more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position a definite brand excellently. With the scrupulous competitor analysis covered in...0 Комментарии 0 Поделились 365 Просмотры 0 предпросмотр
-
Will HER2 Inhibitors Continue to Revolutionize Targeted Cancer Therapy?HER2 Inhibitors Market Summary: According to the latest report published by Data Bridge Market Research, the HER2 Inhibitors Market CAGR Value With the clear understanding of customer requirement, one method or combination of many have been used to construct the most excellent HER2 Inhibitors Market research report. The report endows with complete market analysis and...0 Комментарии 0 Поделились 696 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek